rs147782061
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PP4_StrongPP3
This summary comes from the ClinGen Evidence Repository: The NM_000212.3(ITGB3):c.356G>A variant predicts a missense change, Arg119Gln. It is reported at a frequency of 0.0001468 (11/74914 alleles) in the gnomAD v4.0.0 African/African-American population, above the <0.0001 threshold for PM2_Supporting. At least 4 GT patients (homozygous and compound heterozygous) with the variant have been reported in the literature (PMIDs: 19691478, 16463284, 25728920). The proband from PMID:25728920 meets criteria for PP4_Strong including bleeding phenotype, abnormal platelet aggregation in response to >2 agonists and normal aggregation to ristocetin, reduced αIIbβ3 integrin expression on flow cytometry and full sequencing of ITGA2B and ITGB3 both genes. The variant has a REVEL score of 0.936, meeting criteria for PP3 (threshold: >0.7). In summary, there is insufficient evidence at this time to classify the Arg119Gln variant. GT-specific criteria met: PP3, PP4_strong. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8622925/MONDO:0010119/011
Frequency
Consequence
NM_000212.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGB3 | NM_000212.3 | c.356G>A | p.Arg119Gln | missense_variant | 3/15 | ENST00000559488.7 | NP_000203.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGB3 | ENST00000559488.7 | c.356G>A | p.Arg119Gln | missense_variant | 3/15 | 1 | NM_000212.3 | ENSP00000452786.2 | ||
ITGB3 | ENST00000571680.1 | c.356G>A | p.Arg119Gln | missense_variant | 3/9 | 1 | ENSP00000461626.1 | |||
ENSG00000259753 | ENST00000560629.1 | n.320G>A | non_coding_transcript_exon_variant | 3/18 | 2 | ENSP00000456711.2 | ||||
ITGB3 | ENST00000696963.1 | c.356G>A | p.Arg119Gln | missense_variant | 3/14 | ENSP00000513002.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249610Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135108
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461844Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 727232
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 119 of the ITGB3 protein (p.Arg119Gln). This variant is present in population databases (rs147782061, gnomAD 0.03%). This missense change has been observed in individuals with autosomal recessive Glanzmann thrombasthenia (PMID: 16463284, 19691478, 25728920). ClinVar contains an entry for this variant (Variation ID: 996208). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ITGB3 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Glanzmann thrombasthenia Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen | Nov 02, 2023 | The NM_000212.3(ITGB3):c.356G>A variant predicts a missense change, Arg119Gln. It is reported at a frequency of 0.0001468 (11/74914 alleles) in the gnomAD v4.0.0 African/African-American population, above the <0.0001 threshold for PM2_Supporting. At least 4 GT patients (homozygous and compound heterozygous) with the variant have been reported in the literature (PMIDs: 19691478, 16463284, 25728920). The proband from PMID: 25728920 meets criteria for PP4_Strong including bleeding phenotype, abnormal platelet aggregation in response to >2 agonists and normal aggregation to ristocetin, reduced αIIbβ3 integrin expression on flow cytometry and full sequencing of ITGA2B and ITGB3 both genes. The variant has a REVEL score of 0.936, meeting criteria for PP3 (threshold: >0.7). In summary, there is insufficient evidence at this time to classify the Arg119Gln variant. GT-specific criteria met: PP3, PP4_strong. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at